Skip to content

New Mexico

Psychedelic trials in New Mexico

12 registered trials has a study site in New Mexico, and 3 are recruiting now.

12
Trials with a site here
3
Recruiting
10
Facilities

Open now

Recruiting in this state

Facilities

Where the research happens in New Mexico

FacilityCityTrials
University of New MexicoAlbuquerque3
University of New Mexico Health Sciences CenterAlbuquerque2
University of New Mexico Health SciencesAlbuquerque1
Duke City Recovery ToolboxAlbuquerque1
Interdisciplinary Substance Use and Brain Injury (ISUBI)Albuquerque1
New Mexico VA Health Care System, Albuquerque, NMAlbuquerque1
University of New Mexico (UNM) Interdisciplinary Substance Use and Brain Injury (ISUBI) CenterAlbuquerque1
Interdisciplinary Substance Use and Brain Injury FacilityAlbuquerque1
Santa Fe MDMA Therapy Training, LLCSanta Fe1
University of New Mexico Mental Health CenterAlbuquerque1

Stay told

When a trial opens in New Mexico

Research alerts

Get a notification when a trial for trials in New Mexico starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

All trials

Every trial with a New Mexico site

TrialStatusPhaseSubstanceSites
MDMA for Co-occurring PTSD and OUD After ChildbirthNCT05219175 · University of New MexicoRecruitingPhase 2mdma1
Psilocybin for Opioid Use Disorder (OUD)NCT06796062 · NYU Langone HealthRecruitingPhase 2psilocybin5
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress DisorderNCT07506395 · University of New MexicoRecruitingPhase 1psilocybin1
VA Aripiprazole vs Esketamine for Treatment Resistant DepressionNCT05554627 · VA Office of Research and DevelopmentWithdrawnPhase 4ketamine26
Psilocybin for Major Depressive Disorder (MDD)NCT06308653 · Usona InstituteActive, not recruitingPhase 3psilocybin29
Ketamine for Methamphetamine Use DisorderNCT06496750 · University of Texas Southwestern Medical CenterActive, not recruitingPhase 2ketamine5
Connectivity Changes Associated With Ketamine Assisted Psychotherapy for PTSDNCT06036511 · University of New MexicoWithdrawnPhase 1 / Phase 2ketamine1
Effects and Therapeutic Potential of Psilocybin in Alcohol DependenceNCT01534494 · University of New MexicoCompletedPhase 2psilocybin1
A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol DependenceNCT02061293 · NYU Langone HealthCompletedPhase 2psilocybin2
Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy VolunteersNCT01404754 · Resilient PharmaceuticalsCompletedPhase 1mdma3
Spreading Depolarization and Ketamine SuppressionNCT02501941 · University of New MexicoCompletedPhase 1ketamine1
EEG Characteristics in ECTNCT04022226 · University of New MexicoCompletedEarly Phase 1ketamine1

Site locations from ClinicalTrials.gov API v2, data build 2026-08-25.

Elsewhere

Other states